ProShare Advisors’s LeonaBio Inc LONA Stock Holding History

ProShare Advisors’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,230	Closed	-$161K	–	2210
2021 Q4	$161K	Buy	+1,230	New	+$156K	﹤0.01%	2105

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ProShare Advisors's LONA Position: Q1 2022 in Review

ProShare Advisors sold out of LeonaBio Inc (LONA) in Q1 2022, closing a stake of 1,230 shares — an estimated $161K sold.

ProShare Advisors first reported a position in LONA in Q4 2021 and held it in 1 quarter. The position peaked at $161K in Q4 2021. 105 funds tracked by Wall St. Rank hold LONA as of Q1 2022.

ProShare Advisors reported no remaining LeonaBio Inc position as of Q1 2022 after selling out during the quarter.
ProShare Advisors sold 1,230 LeonaBio Inc shares in Q1 2022, an estimated $161K.
ProShare Advisors first reported a position in LeonaBio Inc in Q4 2021 and held it in 1 quarter.
ProShare Advisors's LeonaBio Inc position peaked at $161K in Q4 2021.
105 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.